BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35628311)

  • 1. Regulation of Neuroinflammatory Signaling by PPARγ Agonist in Mouse Model of Diabetes.
    Piątkowska-Chmiel I; Herbet M; Gawrońska-Grzywacz M; Dudka J
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone attenuates ischaemic stroke aggravation by blocking PPARγ reduction and inhibiting chronic inflammation in diabetic mice.
    Guo Y; Zuo W; Yin L; Gu T; Wang S; Fang Z; Wang B; Dong H; Hou W; Zuo Z; Deng J
    Eur J Neurosci; 2022 Sep; 56(6):4948-4961. PubMed ID: 35945686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A selective peroxisome proliferator-activated receptor-γ agonist benefited propionic acid induced autism-like behavioral phenotypes in rats by attenuation of neuroinflammation and oxidative stress.
    Mirza R; Sharma B
    Chem Biol Interact; 2019 Sep; 311():108758. PubMed ID: 31348919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARγ agonist pioglitazone reverses memory impairment and biochemical changes in a mouse model of type 2 diabetes mellitus.
    Jiang LY; Tang SS; Wang XY; Liu LP; Long Y; Hu M; Liao MX; Ding QL; Hu W; Li JC; Hong H
    CNS Neurosci Ther; 2012 Aug; 18(8):659-66. PubMed ID: 22620268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARγ-mediated microglial activation phenotype is involved in depressive-like behaviors and neuroinflammation in stressed C57BL/6J and ob/ob mice.
    Qin X; Wang W; Wu H; Liu D; Wang R; Xu J; Jiang H; Pan F
    Psychoneuroendocrinology; 2020 Jul; 117():104674. PubMed ID: 32422516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antidepressant-like effects of pioglitazone in a chronic mild stress mouse model are associated with PPARγ-mediated alteration of microglial activation phenotypes.
    Zhao Q; Wu X; Yan S; Xie X; Fan Y; Zhang J; Peng C; You Z
    J Neuroinflammation; 2016 Oct; 13(1):259. PubMed ID: 27716270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome Proliferator-Activated Receptor-gamma agonists exhibit anti-inflammatory and antiviral effects in an EcoHIV mouse model.
    Omeragic A; Kara-Yacoubian N; Kelschenbach J; Sahin C; Cummins CL; Volsky DJ; Bendayan R
    Sci Rep; 2019 Jul; 9(1):9428. PubMed ID: 31263138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone ameliorates memory deficits in streptozotocin-induced diabetic mice by reducing brain β-amyloid through PPARγ activation.
    Liu LP; Yan TH; Jiang LY; Hu W; Hu M; Wang C; Zhang Q; Long Y; Wang JQ; Li YQ; Hu M; Hong H
    Acta Pharmacol Sin; 2013 Apr; 34(4):455-63. PubMed ID: 23524568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone-Mediated Peroxisome Proliferator-Activated Receptor γ Activation Aggravates Murine Immune-Mediated Hepatitis.
    Schulte R; Wohlleber D; Unrau L; Geers B; Metzger C; Erhardt A; Tiegs G; van Rooijen N; Heukamp LC; Klotz L; Knolle PA; Diehl L
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARγ activation ameliorates postoperative cognitive decline probably through suppressing hippocampal neuroinflammation in aged mice.
    Zhang Z; Yuan H; Zhao H; Qi B; Li F; An L
    Int Immunopharmacol; 2017 Feb; 43():53-61. PubMed ID: 27940378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of epidermal growth factor with COX-2 products and peroxisome proliferator-activated receptor-γ system in experimental rat Barrett's esophagus.
    Majka J; Wierdak M; Szlachcic A; Magierowski M; Targosz A; Urbanczyk K; Krzysiek-Maczka G; Ptak-Belowska A; Bakalarz D; Magierowska K; Chmura A; Brzozowski T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G375-G389. PubMed ID: 31928220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of PPARγ agonist pioglitazone on cardiac fibrosis in diabetic mice by regulating PTEN/AKT/FAK pathway.
    Zhang XD; Sun GX; Guo JJ; Hu CC; Sun RC; Yu HC
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):812-819. PubMed ID: 33577036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of ranolazine versus pioglitazone in experimental diabetic neuropathy: Targeting Nav1.7 channels and PPAR-γ.
    Elkholy SE; Elaidy SM; El-Sherbeeny NA; Toraih EA; El-Gawly HW
    Life Sci; 2020 Jun; 250():117557. PubMed ID: 32184124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARγ agonist pioglitazone inhibits microglia inflammation by blocking p38 mitogen-activated protein kinase signaling pathways.
    Ji H; Wang H; Zhang F; Li X; Xiang L; Aiguo S
    Inflamm Res; 2010 Nov; 59(11):921-9. PubMed ID: 20495845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Molecular and Inflammatory Indicators in the Assessment of Cognitive Dysfunction in a Mouse Model of Diabetes.
    Piatkowska-Chmiel I; Herbet M; Gawronska-Grzywacz M; Ostrowska-Lesko M; Dudka J
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of KY-903, a Novel Tetrazole-Based Peroxisome Proliferator-Activated Receptor γ Modulator, in Male Diabetic Mice and Female Ovariectomized Rats.
    Ito Y; Yamamoto M; Furukawa S; Fukui M; Morishita K; Kitao T; Shirahase H
    Biol Pharm Bull; 2021; 44(5):659-668. PubMed ID: 33952822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against alcohol-induced neuronal and cognitive damage by the PPARγ receptor agonist pioglitazone.
    Cippitelli A; Domi E; Ubaldi M; Douglas JC; Li HW; Demopulos G; Gaitanaris G; Roberto M; Drew PD; Kane CJM; Ciccocioppo R
    Brain Behav Immun; 2017 Aug; 64():320-329. PubMed ID: 28167117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence for the involvement of the PPARγ system on alcohol intake and sensitivity in rodents.
    Domi E; Domi A; Ubaldi M; Somaini L; Demopulos G; Gaitanaris G; Ciccocioppo R
    Psychopharmacology (Berl); 2020 Oct; 237(10):2983-2992. PubMed ID: 32676772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPAR gamma agonist, pioglitazone, rescues liver damage induced by renal ischemia/reperfusion injury.
    Elshazly S; Soliman E
    Toxicol Appl Pharmacol; 2019 Jan; 362():86-94. PubMed ID: 30393147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bis(ethylmaltolato)oxidovanadium (IV) attenuates amyloid-beta-mediated neuroinflammation by inhibiting NF-κB signaling pathway via a PPARγ-dependent mechanism.
    He Z; Li X; Han S; Ren B; Hu X; Li N; Du X; Ni J; Yang X; Liu Q
    Metallomics; 2021 Jul; 13(7):. PubMed ID: 34124763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.